For Admin

Japanese

A Leading Company in Nasal Drug Delivery

SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.

For Absorption

For Vaccination

For Nose-to-Brain

3D Nasal Cast Model

News

2019.02.21

Satsuma Pharmaceuticals, Inc. announces advance of lead product candidate, STS101, into Phase 3 Efficacy Trial for Acute Migraine in 2019

2018.06.19

Event: SNBL will exhibit a booth showcasing our nasal delivery technology at WCP 2018 KYOTO

2018.06.15

Event: SNBL to present in vitro/in vivo evaluations of proprietary Nose-to-Brain delivery technology at CRS Annual Meeting 2018

2018.04.02